{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T15:59:27Z","timestamp":1776959967576,"version":"3.51.4"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study sought to evaluate the association of 28 single nucleotide polymorphisms (SNPs) within NFKB and inflammasome pathway genes with the risk of rheumatoid arthritis (RA) and response to TNF inhibitors (TNFi). We conducted a case-control study in a European population of 1194 RA patients and 1328 healthy controls. The association of potentially interesting markers was validated with data from the DANBIO (695 RA patients and 978 healthy controls) and DREAM (882 RA patients) registries. The meta-analysis of our data with those from the DANBIO registry confirmed that anti-citrullinated protein antibodies (ACPA)-positive subjects carrying the NFKB2<jats:sub>rs11574851T<\/jats:sub> allele had a significantly increased risk of developing RA (PMeta_ACPA\u2009+\u2009=\u20090.0006) whereas no significant effect was found in ACPA-negative individuals (PMeta_ACPA\u2212\u2009=\u20090.35). An ACPA-stratified haplotype analysis including both cohorts (n\u2009=\u20094210) confirmed that ACPA-positive subjects carrying the NFKB2<jats:sub>TT<\/jats:sub> haplotype had an increased risk of RA (OR\u2009=\u20091.39, P\u2009=\u20090.0042) whereas no effect was found in ACPA-negative subjects (OR\u2009=\u20091.04, P\u2009=\u20090.82). The meta-analysis of our data with those from the DANBIO and DREAM registries also revealed a suggestive association of the NFKB2<jats:sub>rs1056890<\/jats:sub> SNP with larger changes in DAS28 (OR\u2009=\u20091.18, P\u2009=\u20090.007). Functional experiments showed that peripheral blood mononuclear cells from carriers of the NFKB2<jats:sub>rs1005044C<\/jats:sub> allele (in LD with the rs1056890, r2\u2009=\u20091.00) showed increased production of IL10 after stimulation with LPS (P\u2009=\u20090.0026). These results provide first evidence of a role of the NFKB2 locus in modulating the risk of RA in an ACPA-dependent manner and suggest its implication in determining the response to TNFi. Additional studies are now warranted to further validate these findings.<\/jats:p>","DOI":"10.1038\/s41598-020-61331-5","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T11:02:46Z","timestamp":1583751766000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["NFKB2 polymorphisms associate with the risk of developing rheumatoid arthritis and response to TNF inhibitors: Results from the REPAIR consortium"],"prefix":"10.1038","volume":"10","author":[{"given":"Jose","family":"Manuel S\u00e1nchez-Maldonado","sequence":"first","affiliation":[]},{"given":"Manuel","family":"Mart\u00ednez-Bueno","sequence":"additional","affiliation":[]},{"given":"Helena","family":"Canh\u00e3o","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0576-5873","authenticated-orcid":false,"given":"Rob","family":"ter Horst","sequence":"additional","affiliation":[]},{"given":"Sonia","family":"Mu\u00f1oz-Pe\u00f1a","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Mo\u00f1iz-D\u00edez","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3422-2886","authenticated-orcid":false,"given":"Ana","family":"Rodr\u00edguez-Ramos","sequence":"additional","affiliation":[]},{"given":"Alejandro","family":"Escudero","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3215-1236","authenticated-orcid":false,"given":"Signe B.","family":"Sorensen","sequence":"additional","affiliation":[]},{"given":"Merete L.","family":"Hetland","sequence":"additional","affiliation":[]},{"given":"Miguel A.","family":"Ferrer","sequence":"additional","affiliation":[]},{"given":"Bente","family":"Glintborg","sequence":"additional","affiliation":[]},{"given":"Ileana","family":"Filipescu","sequence":"additional","affiliation":[]},{"given":"Eva","family":"P\u00e9rez-Pampin","sequence":"additional","affiliation":[]},{"given":"Pablo","family":"Conesa-Zamora","sequence":"additional","affiliation":[]},{"given":"Antonio","family":"Garc\u00eda","sequence":"additional","affiliation":[]},{"given":"Alfons","family":"den Broeder","sequence":"additional","affiliation":[]},{"given":"Salvatore","family":"De Vita","sequence":"additional","affiliation":[]},{"given":"Svend Erik","family":"Hove Jacobsen","sequence":"additional","affiliation":[]},{"given":"Eduardo","family":"Collantes","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0134-6439","authenticated-orcid":false,"given":"Luca","family":"Quartuccio","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2421-6052","authenticated-orcid":false,"given":"Mihai G.","family":"Netea","sequence":"additional","affiliation":[]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o E.","family":"Fonseca","sequence":"additional","affiliation":[]},{"given":"Manuel","family":"Jurado","sequence":"additional","affiliation":[]},{"given":"Miguel \u00c1ngel","family":"L\u00f3pez-Nevot","sequence":"additional","affiliation":[]},{"given":"Marieke J. H.","family":"Coenen","sequence":"additional","affiliation":[]},{"given":"Vibeke","family":"Andersen","sequence":"additional","affiliation":[]},{"given":"Rafael","family":"C\u00e1liz","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9355-2423","authenticated-orcid":false,"given":"Juan","family":"Sainz","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,3,9]]},"reference":[{"issue":"Suppl 3","key":"61331_CR1","doi-asserted-by":"publisher","first-page":"S265","DOI":"10.1186\/ar578","volume":"4","author":"AJ Silman","year":"2002","unstructured":"Silman, A. J. & Pearson, J. E. Epidemiology and genetics of rheumatoid arthritis. Arthritis Res. 4(Suppl 3), S265\u2013272 (2002).","journal-title":"Arthritis Res."},{"key":"61331_CR2","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes, I. B. & Schett, G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365, 2205\u20132219 (2011).","journal-title":"N. Engl. J. Med."},{"key":"61331_CR3","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","volume":"336","author":"PJ Barnes","year":"1997","unstructured":"Barnes, P. J. & Karin, M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336, 1066\u20131071 (1997).","journal-title":"N. Engl. J. Med."},{"key":"61331_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3109\/08916939808995367","volume":"28","author":"Z Han","year":"1998","unstructured":"Han, Z., Boyle, D. L., Manning, A. M. & Firestein, G. S. AP-1 and NF-kappaB regulation in rheumatoid arthritis and murine collagen-induced arthritis. Autoimmunity 28, 197\u2013208 (1998).","journal-title":"Autoimmunity"},{"key":"61331_CR5","first-page":"827","volume":"37","author":"H Asahara","year":"1995","unstructured":"Asahara, H., Asanuma, M., Ogawa, N., Nishibayashi, S. & Inoue, H. High DNA-binding activity of transcription factor NF-kappa B in synovial membranes of patients with rheumatoid arthritis. Biochem. Mol. Biol. Int. 37, 827\u2013832 (1995).","journal-title":"Biochem. Mol. Biol. Int."},{"key":"61331_CR6","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/art.1780390407","volume":"39","author":"R Marok","year":"1996","unstructured":"Marok, R. et al. Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue. Arthritis rheumatism 39, 583\u2013591 (1996).","journal-title":"Arthritis rheumatism"},{"key":"61331_CR7","doi-asserted-by":"publisher","first-page":"518S","DOI":"10.1042\/bst025518s","volume":"25","author":"V Gilston","year":"1997","unstructured":"Gilston, V. et al. NF-kappa B activation in human knee-joint synovial tissue during the early stage of joint inflammation. Biochemical Soc. Trans. 25, 518S (1997).","journal-title":"Biochemical Soc. Trans."},{"key":"61331_CR8","first-page":"793","volume":"152","author":"K Miyazawa","year":"1998","unstructured":"Miyazawa, K., Mori, A., Yamamoto, K. & Okudaira, H. Constitutive transcription of the human interleukin-6 gene by rheumatoid synoviocytes: spontaneous activation of NF-kappaB and CBF1. Am. J. Pathol. 152, 793\u2013803 (1998).","journal-title":"Am. J. Pathol."},{"key":"61331_CR9","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S1097-2765(02)00697-4","volume":"10","author":"JL Pomerantz","year":"2002","unstructured":"Pomerantz, J. L. & Baltimore, D. Two pathways to NF-kappaB. Mol. Cell 10, 693\u2013695 (2002).","journal-title":"Mol. Cell"},{"key":"61331_CR10","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/ar300","volume":"3","author":"SS Makarov","year":"2001","unstructured":"Makarov, S. S. NF-kappa B in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destruction. Arthritis Res. 3, 200\u2013206 (2001).","journal-title":"Arthritis Res."},{"key":"61331_CR11","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.4049\/jimmunol.167.4.1909","volume":"167","author":"DS Weih","year":"2001","unstructured":"Weih, D. S., Yilmaz, Z. B. & Weih, F. Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines. J. immunology 167, 1909\u20131919 (2001).","journal-title":"J. immunology"},{"key":"61331_CR12","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1074-7613(02)00423-5","volume":"17","author":"E Dejardin","year":"2002","unstructured":"Dejardin, E. et al. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immun. 17, 525\u2013535 (2002).","journal-title":"Immun."},{"key":"61331_CR13","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1128\/MCB.01469-07","volume":"28","author":"S Basak","year":"2008","unstructured":"Basak, S., Shih, V. F. & Hoffmann, A. Generation and activation of multiple dimeric transcription factors within the NF-kappaB signaling system. Mol. Cell. Biol. 28, 3139\u20133150 (2008).","journal-title":"Mol. Cell. Biol."},{"key":"61331_CR14","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1073\/pnas.0708576105","volume":"105","author":"S Vaira","year":"2008","unstructured":"Vaira, S. et al. RelB is the NF-kappaB subunit downstream of NIK responsible for osteoclast differentiation. Proc. Natl Acad. Sci. U S Am. 105, 3897\u20133902 (2008).","journal-title":"Proc. Natl Acad. Sci. U S Am."},{"key":"61331_CR15","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S1074-7613(00)80649-4","volume":"9","author":"L Wu","year":"1998","unstructured":"Wu, L. et al. RelB is essential for the development of myeloid-related CD8alpha- dendritic cells but not of lymphoid-related CD8alpha+ dendritic cells. Immun. 9, 839\u2013847 (1998).","journal-title":"Immun."},{"key":"61331_CR16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/cei.13167","volume":"194","author":"C Guo","year":"2018","unstructured":"Guo, C. et al. NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis. Clin. Exp. immunology 194, 231\u2013243 (2018).","journal-title":"Clin. Exp. immunology"},{"key":"61331_CR17","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1136\/ard.2008.106989","volume":"69","author":"A Kastbom","year":"2010","unstructured":"Kastbom, A., Johansson, M., Verma, D., Soderkvist, P. & Rantapaa-Dahlqvist, S. CARD8 p.C10X polymorphism is associated with inflammatory activity in early rheumatoid arthritis. Ann. rheumatic Dis. 69, 723\u2013726 (2010).","journal-title":"Ann. rheumatic Dis."},{"key":"61331_CR18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/rheumatology\/kem372","volume":"47","author":"A Kastbom","year":"2008","unstructured":"Kastbom, A. et al. Genetic variation in proteins of the cryopyrin inflammasome influences susceptibility and severity of rheumatoid arthritis (the Swedish TIRA project). Rheumatol. 47, 415\u2013417 (2008).","journal-title":"Rheumatol."},{"key":"61331_CR19","doi-asserted-by":"publisher","first-page":"e34977","DOI":"10.1371\/journal.pone.0034977","volume":"7","author":"D Verma","year":"2012","unstructured":"Verma, D. et al. The Q705K polymorphism in NLRP3 is a gain-of-function alteration leading to excessive interleukin-1beta and IL-18 production. PLoS one 7, e34977 (2012).","journal-title":"PLoS one"},{"key":"61331_CR20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett, F. C. et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31, 315\u2013324 (1988).","journal-title":"Arthritis Rheum."},{"key":"61331_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/art.1780390105","volume":"39","author":"AM van Gestel","year":"1996","unstructured":"van Gestel, A. M. et al. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization\/International League Against Rheumatism Criteria. Arthritis Rheum. 39, 34\u201340 (1996).","journal-title":"Arthritis Rheum."},{"key":"61331_CR22","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/FPC.0000000000000155","volume":"25","author":"LM Canet","year":"2015","unstructured":"Canet, L. M. et al. Genetic variants within the TNFRSF1B gene and susceptibility to rheumatoid arthritis and response to anti-TNF drugs: a multicenter study. Pharmacogenet Genomics 25, 432\u2013443 (2015).","journal-title":"Pharmacogenet Genomics"},{"key":"61331_CR23","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/FPC.0000000000000155","volume":"25","author":"LM Canet","year":"2015","unstructured":"Canet, L. M. et al. Genetic variants within immune-modulating genes influence the risk of developing rheumatoid arthritis and anti-TNF drug response: a two-stage case-control study. Pharmacogenet Genomics 25, 432\u2013443 (2015).","journal-title":"Pharmacogenet Genomics"},{"key":"61331_CR24","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/FPC.0000000000000140","volume":"25","author":"LM Canet","year":"2015","unstructured":"Canet, L. M. et al. Genetic variants within the TNFRSF1B gene and susceptibility to rheumatoid arthritis and response to anti-TNF drugs: a multicenter study. Pharmacogenet Genomics 25, 323\u2013333 (2015).","journal-title":"Pharmacogenet Genomics"},{"key":"61331_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/tpj.2016.66","volume":"18","author":"J Sode","year":"2018","unstructured":"Sode, J. et al. Confirmation of an IRAK3 polymorphism as a genetic marker predicting response to anti-TNF treatment in rheumatoid arthritis. Pharmacogenomics J. 18, 81\u201386 (2018).","journal-title":"Pharmacogenomics J."},{"key":"61331_CR26","doi-asserted-by":"publisher","first-page":"575","DOI":"10.2119\/2008-00056.Liu","volume":"14","author":"C Liu","year":"2008","unstructured":"Liu, C. et al. Genome-wide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in rheumatoid arthritis. Mol. Med. 14, 575\u2013581 (2008).","journal-title":"Mol. Med."},{"key":"61331_CR27","doi-asserted-by":"publisher","first-page":"e0139781","DOI":"10.1371\/journal.pone.0139781","volume":"10","author":"J Sode","year":"2015","unstructured":"Sode, J. et al. Genetic Variations in Pattern Recognition Receptor Loci Are Associated with Anti-TNF Response in Patients with Rheumatoid Arthritis. PLoS one 10, e0139781 (2015).","journal-title":"PLoS one"},{"key":"61331_CR28","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/tpj.2017.26","volume":"17","author":"S Bek","year":"2017","unstructured":"Bek, S. et al. Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis. Pharmacogenomics J. 17, 403\u2013411 (2017).","journal-title":"Pharmacogenomics J."},{"key":"61331_CR29","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/ng.395","volume":"41","author":"PK Gregersen","year":"2009","unstructured":"Gregersen, P. K. et al. REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis. Nat. Genet. 41, 820\u2013823 (2009).","journal-title":"Nat. Genet."},{"key":"61331_CR30","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1086\/383251","volume":"74","author":"DR Nyholt","year":"2004","unstructured":"Nyholt, D. R. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am. J. Hum. Genet. 74, 765\u2013769 (2004).","journal-title":"Am. J. Hum. Genet."},{"key":"61331_CR31","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1093\/bioinformatics\/btl268","volume":"22","author":"X Sole","year":"2006","unstructured":"Sole, X., Guino, E., Valls, J., Iniesta, R. & Moreno, V. SNPStats: a web tool for the analysis of association studies. Bioinforma. 22, 1928\u20131929 (2006).","journal-title":"Bioinforma."},{"key":"61331_CR32","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1126\/science.1069424","volume":"296","author":"SB Gabriel","year":"2002","unstructured":"Gabriel, S. B. et al. The structure of haplotype blocks in the human genome. Sci. 296, 2225\u20132229 (2002).","journal-title":"Sci."},{"key":"61331_CR33","doi-asserted-by":"crossref","unstructured":"Canet, L. M. et al. Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients. Pharmacogenomics J. (2018).","DOI":"10.1038\/s41397-018-0057-x"},{"key":"61331_CR34","doi-asserted-by":"publisher","first-page":"737","DOI":"10.2147\/CLEP.S99490","volume":"8","author":"EH Ibfelt","year":"2016","unstructured":"Ibfelt, E. H., Jensen, D. V. & Hetland, M. L. The Danish nationwide clinical register for patients with rheumatoid arthritis: DANBIO. Clin. Epidemiol. 8, 737\u2013742 (2016).","journal-title":"Clin. Epidemiol."},{"key":"61331_CR35","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.cell.2016.10.017","volume":"167","author":"Y Li","year":"2016","unstructured":"Li, Y. et al. A Functional Genomics Approach to Understand Variation in Cytokine Production in Humans. Cell 167, 1099\u20131110 e1014 (2016).","journal-title":"Cell"},{"key":"61331_CR36","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/j.cell.2016.11.046","volume":"167","author":"M Schirmer","year":"2016","unstructured":"Schirmer, M. et al. Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity. Cell 167, 1897 (2016).","journal-title":"Cell"},{"key":"61331_CR37","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.cell.2016.10.018","volume":"167","author":"R Ter Horst","year":"2016","unstructured":"Ter Horst, R. et al. Host and Environmental Factors Influencing Individual Human Cytokine Responses. Cell 167, 1111\u20131124 e1113 (2016).","journal-title":"Cell"},{"key":"61331_CR38","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1136\/annrheumdis-2011-201225","volume":"71","author":"S Viatte","year":"2012","unstructured":"Viatte, S. et al. Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients. Ann. rheumatic Dis. 71, 1984\u20131990 (2012).","journal-title":"Ann. rheumatic Dis."},{"key":"61331_CR39","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1136\/ard.2009.126821","volume":"70","author":"L Padyukov","year":"2011","unstructured":"Padyukov, L. et al. A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis. Ann. rheumatic Dis. 70, 259\u2013265 (2011).","journal-title":"Ann. rheumatic Dis."},{"key":"61331_CR40","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/rheumatology\/kev285","volume":"55","author":"X Jiang","year":"2016","unstructured":"Jiang, X. et al. An Immunochip-based interaction study of contrasting interaction effects with smoking in ACPA-positive versus ACPA-negative rheumatoid arthritis. Rheumatol. 55, 149\u2013155 (2016).","journal-title":"Rheumatol."},{"key":"61331_CR41","doi-asserted-by":"crossref","unstructured":"Dong, X. et al. ACPAs promote IL-1beta production in rheumatoid arthritis by activating the NLRP3 inflammasome. Cellular & molecular immunology, (2019).","DOI":"10.1038\/s41423-019-0201-9"},{"key":"61331_CR42","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1111\/apt.15187","volume":"49","author":"S Bank","year":"2019","unstructured":"Bank, S. et al. Polymorphisms in the NFkB, TNF-alpha, IL-1beta, and IL-18 pathways are associated with response to anti-TNF therapy in Danish patients with inflammatory bowel disease. Alimentary pharmacology therapeutics 49, 890\u2013903 (2019).","journal-title":"Alimentary pharmacology therapeutics"},{"key":"61331_CR43","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1101\/gr.137323.112","volume":"22","author":"AP Boyle","year":"2012","unstructured":"Boyle, A. P. et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 22, 1790\u20131797 (2012).","journal-title":"Genome Res."},{"key":"61331_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/srep16783","volume":"5","author":"Y Zhang","year":"2015","unstructured":"Zhang, Y. et al. Endochondral ossification pathway genes and postmenopausal osteoporosis: Association and specific allele related serum bone sialoprotein levels in Han Chinese. Sci. Rep. 5, 16783 (2015).","journal-title":"Sci. Rep."},{"issue":"Suppl 12","key":"61331_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-11-S12-S12","volume":"11","author":"MA Swertz","year":"2010","unstructured":"Swertz, M. A. et al. The MOLGENIS toolkit: rapid prototyping of biosoftware at the push of a button. BMC Bioinforma. 11(Suppl 12), S12 (2010).","journal-title":"BMC Bioinforma."},{"key":"61331_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2016.18","volume":"3","author":"MD Wilkinson","year":"2016","unstructured":"Wilkinson, M. D. et al. The FAIR Guiding Principles for scientific data management and stewardship. Sci. Data 3, 160018 (2016).","journal-title":"Sci. Data"},{"key":"61331_CR47","doi-asserted-by":"publisher","first-page":"631","DOI":"10.2217\/pgs-2017-0014","volume":"18","author":"MC Ovejero-Benito","year":"2017","unstructured":"Ovejero-Benito, M. C. et al. Polymorphisms associated with etanercept response in moderate-to-severe plaque psoriasis. Pharmacogenomics 18, 631\u2013638 (2017).","journal-title":"Pharmacogenomics"},{"key":"61331_CR48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ajhg.2018.11.008","volume":"104","author":"G Kichaev","year":"2019","unstructured":"Kichaev, G. et al. Leveraging Polygenic Functional Enrichment to Improve GWAS Power. Am. J. Hum. Genet. 104, 65\u201375 (2019).","journal-title":"Am. J. Hum. Genet."},{"key":"61331_CR49","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jbspin.2015.06.010","volume":"83","author":"M Iwaszko","year":"2016","unstructured":"Iwaszko, M. et al. Influence of CD94 and NKG2A variants on susceptibility to rheumatoid arthritis and efficacy of anti-TNF treatment. Jt. Bone Spine 83, 75\u201379 (2016).","journal-title":"Jt. Bone Spine"},{"key":"61331_CR50","doi-asserted-by":"crossref","unstructured":"Iwaszko, M. et al. Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis. Genes (Basel) 9 (2018).","DOI":"10.3390\/genes9020064"},{"key":"61331_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14357","volume":"8","author":"K Suhre","year":"2017","unstructured":"Suhre, K. et al. Connecting genetic risk to disease end points through the human blood plasma proteome. Nat. Commun. 8, 14357 (2017).","journal-title":"Nat. Commun."},{"key":"61331_CR52","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s11033-011-0868-1","volume":"39","author":"P Piotrowski","year":"2012","unstructured":"Piotrowski, P., Lianeri, M., Olesinska, M. & Jagodzinski, P. P. Prevalence of the NKG2D Thr72Ala polymorphism in patients with systemic lupus erythematosus. Mol. Biol. Rep. 39, 1343\u20131347 (2012).","journal-title":"Mol. Biol. Rep."},{"key":"61331_CR53","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.humimm.2009.09.352","volume":"71","author":"G Kabalak","year":"2010","unstructured":"Kabalak, G. et al. Association of an NKG2D gene variant with systemic lupus erythematosus in two populations. Hum. Immunol. 71, 74\u201378 (2010).","journal-title":"Hum. Immunol."},{"key":"61331_CR54","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/ng.582","volume":"42","author":"EA Stahl","year":"2010","unstructured":"Stahl, E. A. et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat. Genet. 42, 508\u2013514 (2010).","journal-title":"Nat. Genet."},{"key":"61331_CR55","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/ng.2462","volume":"44","author":"S Eyre","year":"2012","unstructured":"Eyre, S. et al. High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat. Genet. 44, 1336\u20131340 (2012).","journal-title":"Nat. Genet."},{"key":"61331_CR56","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1111\/bjd.12106","volume":"168","author":"FR Ali","year":"2013","unstructured":"Ali, F. R. et al. An investigation of rheumatoid arthritis loci in patients with early-onset psoriasis validates association of the REL gene. Br. J. Dermatol. 168, 864\u2013866 (2013).","journal-title":"Br. J. Dermatol."},{"key":"61331_CR57","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1136\/ard.2010.134593","volume":"70","author":"J Varade","year":"2011","unstructured":"Varade, J. et al. Analysis of the REL polymorphism rs13031237 in autoimmune diseases. Ann. rheumatic Dis. 70, 711\u2013712 (2011).","journal-title":"Ann. rheumatic Dis."},{"key":"61331_CR58","doi-asserted-by":"publisher","first-page":"e0147350","DOI":"10.1371\/journal.pone.0147350","volume":"11","author":"F Chen","year":"2016","unstructured":"Chen, F. et al. Genetic Variation in the REL Gene Increases Risk of Behcet\u2019s Disease in a Chinese Han Population but That of PRKCQ Does Not. PLoS one 11, e0147350 (2016).","journal-title":"PLoS one"},{"key":"61331_CR59","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/jid.2011.415","volume":"132","author":"E Ellinghaus","year":"2012","unstructured":"Ellinghaus, E. et al. Genome-wide meta-analysis of psoriatic arthritis identifies susceptibility locus at REL. J. Invest. Dermatol. 132, 1133\u20131140 (2012).","journal-title":"J. Invest. Dermatol."},{"key":"61331_CR60","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1136\/annrheumdis-2011-200802","volume":"71","author":"J Bowes","year":"2012","unstructured":"Bowes, J. et al. Comprehensive assessment of rheumatoid arthritis susceptibility loci in a large psoriatic arthritis cohort. Ann. rheumatic Dis. 71, 1350\u20131354 (2012).","journal-title":"Ann. rheumatic Dis."},{"key":"61331_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-28597-2","volume":"8","author":"H Tang","year":"2018","unstructured":"Tang, H. et al. TLR10 and NFKBIA contributed to the risk of hip osteoarthritis: systematic evaluation based on Han Chinese population. Sci. Rep. 8, 10243 (2018).","journal-title":"Sci. Rep."},{"key":"61331_CR62","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1002\/jor.23823","volume":"36","author":"G Vrgoc","year":"2018","unstructured":"Vrgoc, G. et al. Interleukin-17 and Toll-like Receptor 10 genetic polymorphisms and susceptibility to large joint osteoarthritis. J. Orthop. Res. 36, 1684\u20131693 (2018).","journal-title":"J. Orthop. Res."},{"key":"61331_CR63","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1111\/1346-8138.13412","volume":"43","author":"R Nishikawa","year":"2016","unstructured":"Nishikawa, R. et al. Genetic prediction of the effectiveness of biologics for psoriasis treatment. J. Dermatol. 43, 1273\u20131277 (2016).","journal-title":"J. Dermatol."},{"key":"61331_CR64","doi-asserted-by":"crossref","unstructured":"Gebura, K. et al. Polymorphisms within Genes Involved in Regulation of the NF-kappaB Pathway in Patients with Rheumatoid Arthritis. Int. J. Mol. Sci. 18 (2017).","DOI":"10.3390\/ijms18071432"},{"key":"61331_CR65","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s12026-018-9061-0","volume":"67","author":"H Wang","year":"2019","unstructured":"Wang, H., Zhou, S., Zhang, J., Lei, S. & Zhou, J. Correlations between TLR polymorphisms and inflammatory bowel disease: a meta-analysis of 49 case-control studies. Immunol. Res. 67, 142\u2013150 (2019).","journal-title":"Immunol. Res."},{"key":"61331_CR66","doi-asserted-by":"publisher","first-page":"e0145302","DOI":"10.1371\/journal.pone.0145302","volume":"10","author":"S Bank","year":"2015","unstructured":"Bank, S. et al. Polymorphisms in the Toll-Like Receptor and the IL-23\/IL-17 Pathways Were Associated with Susceptibility to Inflammatory Bowel Disease in a Danish Cohort. PLoS one 10, e0145302 (2015).","journal-title":"PLoS one"},{"key":"61331_CR67","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/tpj.2016.84","volume":"18","author":"S Bank","year":"2018","unstructured":"Bank, S. et al. Genetically determined high activity of IL-12 and IL-18 in ulcerative colitis and TLR5 in Crohns disease were associated with non-response to anti-TNF therapy. Pharmacogenomics J. 18, 87\u201397 (2018).","journal-title":"Pharmacogenomics J."},{"key":"61331_CR68","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/tpj.2017.31","volume":"18","author":"ND Loft","year":"2018","unstructured":"Loft, N. D. et al. Associations between functional polymorphisms and response to biological treatment in Danish patients with psoriasis. Pharmacogenomics J. 18, 494\u2013500 (2018).","journal-title":"Pharmacogenomics J."},{"key":"61331_CR69","doi-asserted-by":"publisher","first-page":"1492092","DOI":"10.1155\/2019\/1492092","volume":"2019","author":"CF Oliveira-Tore","year":"2019","unstructured":"Oliveira-Tore, C. F. et al. Genetic Polymorphisms of Toll-like receptors 2 and 9 as Susceptibility Factors for the Development of Ankylosing Spondylitis and Psoriatic Arthritis. J. Immunol. Res. 2019, 1492092 (2019).","journal-title":"J. Immunol. Res."},{"key":"61331_CR70","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1089\/gtmb.2019.0010","volume":"23","author":"X Yi","year":"2019","unstructured":"Yi, X., Xu, E., Xiao, Y. & Cai, X. Evaluation of the Relationship Between Common Variants in the TLR-9 Gene and Hip Osteoarthritis Susceptibility. Genet. Test. Mol. Biomarkers 23, 373\u2013379 (2019).","journal-title":"Genet. Test. Mol. Biomarkers"},{"key":"61331_CR71","doi-asserted-by":"crossref","unstructured":"Zheng, M. et al. Association between TLR-9 gene rs187084 polymorphism and knee osteoarthritis in a Chinese population. Bioscience reports 37 (2017).","DOI":"10.1042\/BSR20170844"},{"key":"61331_CR72","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1007\/s00296-011-1925-8","volume":"32","author":"CM Huang","year":"2012","unstructured":"Huang, C. M. et al. Association of toll-like receptor 9 gene polymorphism in Chinese patients with systemic lupus erythematosus in Taiwan. Rheumatol. Int. 32, 2105\u20132109 (2012).","journal-title":"Rheumatol. Int."},{"key":"61331_CR73","doi-asserted-by":"publisher","first-page":"e98815","DOI":"10.1371\/journal.pone.0098815","volume":"9","author":"S Bank","year":"2014","unstructured":"Bank, S. et al. Polymorphisms in the inflammatory pathway genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG are associated with susceptibility of inflammatory bowel disease in a Danish cohort. PLoS one 9, e98815 (2014).","journal-title":"PLoS one"},{"key":"61331_CR74","doi-asserted-by":"publisher","first-page":"2304218","DOI":"10.1155\/2017\/2304218","volume":"2017","author":"WK Cho","year":"2017","unstructured":"Cho, W. K. et al. Association of Polymorphisms in Toll-Like Receptors 4 and 9 with Autoimmune Thyroid Disease in Korean Pediatric Patients. Int. J. Endocrinol. 2017, 2304218 (2017).","journal-title":"Int. J. Endocrinol."},{"key":"61331_CR75","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/tpj.2014.19","volume":"14","author":"S Bank","year":"2014","unstructured":"Bank, S. et al. Associations between functional polymorphisms in the NFkappaB signaling pathway and response to anti-TNF treatment in Danish patients with inflammatory bowel disease. Pharmacogenomics J. 14, 526\u2013534 (2014).","journal-title":"Pharmacogenomics J."},{"key":"61331_CR76","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa073491","volume":"357","author":"RM Plenge","year":"2007","unstructured":"Plenge, R. M. et al. TRAF1-C5 as a risk locus for rheumatoid arthritis\u2013a genomewide study. N. Engl. J. Med. 357, 1199\u20131209 (2007).","journal-title":"N. Engl. J. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61331-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61331-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61331-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T08:15:41Z","timestamp":1670314541000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61331-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,9]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["61331"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-61331-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,9]]},"assertion":[{"value":"13 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"V.A. has received compensation for consultancy and for being a member of an advisory board from MSD (Merck) and Janssen. B.G. received funding for research from AbbVie, Biogen, and Pfizer. M.L.H. received funding for research from Abbvie, Biogen, BMS, CellTrion, MSD, Novartis, Orion, Pfizer, Samsung and UCB. The rest of authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4316"}}